Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bohen Sean, Chief Executive Officer. Insider active across 1 company, notably Olema Pharmaceuticals, Inc.. Cumulatively, 13 filings have been recorded. Split: 1 buy · 0 sell. Activity tracked since 1 September 2021. The latest transaction was filed on 26 December 2025 (Don). Regulator: SEC (Form 4). The full history is openly available.
871 shares@ US$4.8245.8% of flowCommon StockSEC:0001415889-21-004247
13 of 13 declarations
About Bohen Sean
Sean Bohen is the Chief Executive Officer at Olema Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and the execution of its business objectives. With a strong background in the industry, he has demonstrated his ability to lead teams and drive growth initiatives. His leadership is crucial for the sustainable development and profitability of the company.